Several experimental studies further demonstrated that ubiquitous transgenic expression of IL-23 p19 contributed to severe colitis 33 and knockdown of IL-12/IL23 p40 ameliorated intestinal inflammation in various experimental colitis model 34. The gene discussed is IL23A; the disease is inflammation.